Maud Rothärmel

5PUBLICATIONS
14CO-AUTHORS
Major global burdens of diseaseTesting, assessment and psychometricsGene and molecular therapyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 02, 2026
Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).

|Apr 01, 2026
Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.

Maud Rothärmel, Lila Mekaoui, François Kazour

|Jan 25, 2026
A prospective multicentre double-blind randomized controlled trial evaluating clinical, cognitive and neural effects of potentiation of electroconvulsive therapy by repetitive transcranial magnetic stimulation in patients with treatment-resistant depression (STIMAGNECT 2).

Léa Clabeau, Virginie Moulier, Bastien Kaczmarek

|Apr 14, 2025
Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study.

Ludovic Samalin, Lila Mekaoui, Maud Rothärmel

|Apr 16, 2021
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).

Virginie Moulier, Mohamed Wassim Krir, Marine Dalmont

Pageof 1

Frequent Collaborators

2 joint publications

Ludovic Samalin

2 joint publications

Lila Mekaoui

2 joint publications

Anne Sauvaget

2 joint publications

Clotilde Wicart